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Background: Low-dose thiazide diuretics are regarded as first-line treatment for hypertension. There is still uncertainty whether these lower 
doses of thiazide and thiazide-like diuretics (LDTD) impair glucose tolerance and lower serum potassium levels when compared to non-thiazide 
antihypertensive agents (NTA), and if they do, whether the magnitude of these effects could be regarded as clinically significant.
Methods: A systematic search was made using MEDLINE. Only articles involving randomized controlled clinical trials that included low dose 
thiazide or thiazide like diuretics (hydrochlorothiazide or chlorthalidone at doses of ≤ 25 mg/day, or bendroflumethiazide at ≤ 5 mg/day) were 
included in this analysis.
Results: Six studies with a total 17,866 subjects were analyzed; 8,743 (49%) subjects were in the LDTD arm while 9,123 (51%) were in the NTA 
arm. The cumulative mean change in the LDTD group in fasting plasma glucose (FPG) was 2.50 ± 15.28 mg/dl and in serum potassium was -0.213 
± 0.0617 mEq/L. The aggregate odds ratio using the random effect model (95% CI) for having an elevated FPG with LDTD versus NTA was 1.210 
(1.089 to 1.346, p<0.001), while that for having decreased serum potassium was 3.291 (1.929 to 5.613, p<0.001).
Conclusions: The observed change in FPG associated with LDTD use does not appear to place patients at clinically significant risk. On the other 
hand, the observed change in serum potassium may be clinically significant in patients whose baseline potassium concentration is low-normal, and 
could predispose at-risk patients such as those with ischemic heart disease to ventricular arrhythmias and even sudden cardiac death. Long term 
studies are needed to assess the clinical effect of LDTD on glucose and potassium homeostasis.
